Aro Biotherapeutics Funding: $42M Raised, Series B (2023)
Aro Biotherapeutics is based in Philadelphia. It has raised $42M in total funding. Latest round: Series B.
Aro Biotherapeutics funding overview
Aro Biotherapeutics is based in Philadelphia. Aro Biotherapeutics has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2023. The round record for Aro Biotherapeutics runs through 2023; nothing later has been disclosed. Investors on record include Cowen Healthcare Investments, Johnson & Johnson Innovation – JJDC, Inc., Northpond Ventures, Healthcap, BVF Partners, L.P.. 5 distinct backers are named across the disclosed rounds.
Aro Biotherapeutics at a glance
Total raised
$42M
Latest round
Series B
Latest round date
November 2023
Headquarters
Philadelphia
Notable investors
Cowen Healthcare Investments, Johnson & Johnson Innovation – JJDC, Inc., Northpond Ventures, Healthcap, BVF Partners, L.P.
Frequently asked about Aro Biotherapeutics funding
How much has Aro Biotherapeutics raised?
Aro Biotherapeutics has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Aro Biotherapeutics?
Cowen Healthcare Investments, Johnson & Johnson Innovation – JJDC, Inc., Northpond Ventures, Healthcap, BVF Partners, L.P. are named among the investors backing Aro Biotherapeutics.
What was the latest Aro Biotherapeutics funding round?
The most recent disclosed round is a Series B, announced in November 2023.
Where is Aro Biotherapeutics based?
Aro Biotherapeutics is based in Philadelphia.
When did Aro Biotherapeutics last raise?
The last disclosed Aro Biotherapeutics round closed in November 2023 at Series B.
We update the Aro Biotherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Philadelphia and their backers are listed below.
